These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8644328)

  • 41. Diagnosis and treatment of acute humoral kidney allograft rejection.
    Gomes AM; Pedroso S; Martins LS; Malheiro J; Viscayno JR; Santos J; Dias L; Henriques AC; Sarmento AM; Cabrita A
    Transplant Proc; 2009 Apr; 41(3):855-8. PubMed ID: 19376371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
    Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
    Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo models of inflammation: immune rejection and skin transplantation in vivo.
    Binet I; Wood KJ
    Methods Mol Biol; 2003; 225():239-48. PubMed ID: 12769492
    [No Abstract]   [Full Text] [Related]  

  • 44. Influence of arterial allograft preparation techniques on chronic vascular rejection: a histological study.
    Nataf P; Guettier C; Bourbon A; Nappi F; Lima L; Dorent R; Pavie A; Gandjbakhch I
    Transplant Proc; 1996 Oct; 28(5):2890-2. PubMed ID: 8908111
    [No Abstract]   [Full Text] [Related]  

  • 45. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
    Hoffmann U; Segerer S; Rümmele P; Krüger B; Pietrzyk M; Hofstädter F; Banas B; Krämer BK
    Nephrol Dial Transplant; 2006 May; 21(5):1373-81. PubMed ID: 16421159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II.
    Marcard T; Ivens K; Grabensee B; Willers R; Helmchen U; Rump LC; Blume C
    Transpl Int; 2008 Dec; 21(12):1153-62. PubMed ID: 18684111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CADI, Canti, Cavi.
    Colvin RB
    Transplantation; 2007 Mar; 83(6):677-8. PubMed ID: 17414694
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of thymostimulin in activating rejection in an experimental small bowel allograft.
    Navarro-Zorraquino M; Güemes A; Lozano R; Larrad L; Pastor C; Soria J; Morandeira MJ; Salinas JC
    Transplant Proc; 1996 Oct; 28(5):2479-81. PubMed ID: 8907912
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunohistochemical study of endothelin-1 (ET-1) in human acute renal allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2003; 54(2):95-100. PubMed ID: 14575417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The revised ISHLT heart biopsy grading scale.
    Billingham M; Kobashigawa JA
    J Heart Lung Transplant; 2005 Nov; 24(11):1709. PubMed ID: 16297769
    [No Abstract]   [Full Text] [Related]  

  • 51. Acute and chronic hepatic allograft rejection: pathology and classification.
    Batts KP
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S21-9. PubMed ID: 10431014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proliferation rate of cells in the interstitial infiltrate in acute kidney allograft rejection.
    Olsen S; Hansen HE
    Transplant Proc; 1996 Feb; 28(1):502-3. PubMed ID: 8644329
    [No Abstract]   [Full Text] [Related]  

  • 53. Risk factors, graft fibrosis, and outcome: making the links.
    Roberts IS
    Transplantation; 2007 Mar; 83(6):679-80. PubMed ID: 17414695
    [No Abstract]   [Full Text] [Related]  

  • 54. International grading scheme for acute rejection in small bowel transplantation: implementation and experience at the University of Miami.
    Ruiz P; Weppler D; Nishida S; Kato T; Selvaggi G; Levi D; Bejarano P; Khaled A; Tryphonopoulos P; Tuteja S; Garcia M; Tzakis A
    Transplant Proc; 2006; 38(6):1683-4. PubMed ID: 16908246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seeking beyond rejection: an update on the differential diagnosis and a practical approach to liver allograft biopsy interpretation.
    Gao ZH
    Adv Anat Pathol; 2009 Mar; 16(2):97-117. PubMed ID: 19550371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of tubulitis in chronic allograft nephropathy: a clinicopathologic study.
    Tsamandas AC; Shapiro R; Jordan M; Demetris AJ; Randhawa PS
    Clin Transplant; 1997 Apr; 11(2):139-41. PubMed ID: 9113451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Banff process-Reloaded: A joint initiative from the Banff Foundation for Allograft Pathology and the American Journal of Transplantation.
    Mengel M; Mannon RB; Feng S
    Am J Transplant; 2024 Mar; 24(3):325-327. PubMed ID: 38431355
    [No Abstract]   [Full Text] [Related]  

  • 58. Serum citrulline is a potential marker for rejection of intestinal allografts.
    Gondolesi G; Fishbein T; Chehade M; Tschernia A; Magid M; Kaufman S; Raymond K; Sansaricq C; LeLeiko N
    Transplant Proc; 2002 May; 34(3):918-20. PubMed ID: 12034238
    [No Abstract]   [Full Text] [Related]  

  • 59. Report of the 2022 Banff Heart Concurrent: Focus on non-human leukocyte antigen antibodies in rejection and the pathology of "mixed" rejection.
    Fedrigo M; Berry GJ; Coutance G; Reed EF; Lin CY; Giarraputo A; Kransdorf E; Thaunat O; Goddard M; Angelini A; Neil DAH; Bruneval P; Duong Van Huyen JP; Loupy A; Miller DV
    Am J Transplant; 2024 Apr; 24(4):533-541. PubMed ID: 37838218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Technofuturism in pathology.
    Solez K
    Curr Opin Organ Transplant; 2010 Feb; 15(1):1. PubMed ID: 20071988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.